These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19046817)

  • 1. Molecular assignment of tissue of origin in cancer of unknown primary may not predict response to therapy or outcome: a systematic literature review.
    Pentheroudakis G; Greco FA; Pavlidis N
    Cancer Treat Rev; 2009 May; 35(3):221-7. PubMed ID: 19046817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site.
    Kodaira M; Yonemori K; Shimoi T; Yoshida A; Yoshida M; Kitano A; Shimomura A; Yunokawa M; Shimizu C; Takiguchi Y; Fujiwara Y; Tamura K
    BMC Cancer; 2018 Feb; 18(1):176. PubMed ID: 29433539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The practical utility of AI-assisted molecular profiling in the diagnosis and management of cancer of unknown primary: an updated review.
    Lorkowski SW; Dermawan JK; Rubin BP
    Virchows Arch; 2024 Feb; 484(2):369-375. PubMed ID: 37999736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective analysis of clinical characteristics and outcomes of patients with carcinoma of unknown primary from three tertiary centers in Australia.
    Boys EL; Gao B; Grimison P; Sutherland S; MacKenzie KL; Reddel RR; Liu J
    Cancer Med; 2024 Mar; 13(6):e7052. PubMed ID: 38523552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CUP Syndrome-Metastatic Malignancy with Unknown Primary Tumor.
    Zaun G; Schuler M; Herrmann K; Tannapfel A
    Dtsch Arztebl Int; 2018 Mar; 115(10):157-162. PubMed ID: 29587959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological Evaluation and Molecular Diagnostic Tests for Peritoneal Metastases with Unknown Primary Site-a Review.
    Bhatt A; Mishra S; Glehen O
    Indian J Surg Oncol; 2023 Jun; 14(Suppl 1):15-29. PubMed ID: 37359927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of molecular management of carcinoma of unknown primary.
    Sivakumaran T; Tothill RW; Mileshkin LR
    Curr Opin Oncol; 2024 Jun; ():. PubMed ID: 39007224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Diminishing Importance of Primary Site Identification in Cancer of Unknown Primary: A Canadian Single-Center Experience.
    Wong B; Vickers MM; Wheatley-Price P
    Front Oncol; 2021; 11():634563. PubMed ID: 33747958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer of unknown primary and the «seed and soil» hypothesis.
    Zolotykh MA; Mingazova LA; Filina YV; Blatt NL; Nesterova AI; Sabirov AG; Rizvanov AA; Miftakhova RR
    Crit Rev Oncol Hematol; 2024 Apr; 196():104297. PubMed ID: 38350543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Whole genome sequencing to find the primary tumour in cancer of unknown primary origin].
    van der Hoeven JJM; Monkhorst K; van de Wouw AJ; Roepman P
    Ned Tijdschr Geneeskd; 2023 Sep; 167():. PubMed ID: 37823879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the molecular landscape of cancer of unknown primary: A comparative analysis with other metastatic cancers.
    Andersen L; Christensen DS; Kjær A; Knudsen M; Andersen AK; Laursen MB; Ahrenfeldt J; Laursen BE; Birkbak NJ
    Mol Oncol; 2024 May; ():. PubMed ID: 38750007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secondary neoplasm to non-hodgkin lymphoma treatment manifesting as a cancer of unknown primary: the first case in literature.
    Bashour G; Kheyrbek N; Dway A; Salloum E; Georgeos M; Alshehabi Z
    Ann Med Surg (Lond); 2024 Apr; 86(4):2348-2351. PubMed ID: 38576933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastases in the Absence of a Primary Tumor: Advances in the Diagnosis and Treatment of CUP Syndrome.
    Neben K; Hübner G; Folprecht G; Jäger D; Krämer A
    Dtsch Arztebl Int; 2008 Oct; 105(43):733-40. PubMed ID: 19623297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic renal cell carcinoma with occult primary: a multicenter prospective cohort.
    Jacquin N; Flippot R; Masliah-Planchon J; Grisay G; Brillet R; Dupain C; Kamal M; Guillou I; Gruel N; Servant N; Gestraud P; Wong J; Cockenpot V; Goncalves A; Selves J; Blons H; Rouleau E; Delattre O; Gervais C; Le Tourneau C; Bièche I; Allory Y; Albigès L; Watson S
    NPJ Precis Oncol; 2024 Jul; 8(1):147. PubMed ID: 39025947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer of unknown primary site.
    Varadhachary GR; Raber MN
    N Engl J Med; 2014 Aug; 371(8):757-65. PubMed ID: 25140961
    [No Abstract]   [Full Text] [Related]  

  • 16. Molecular profiling diagnosis in unknown primary cancer: accuracy and ability to complement standard pathology.
    Greco FA; Lennington WJ; Spigel DR; Hainsworth JD
    J Natl Cancer Inst; 2013 Jun; 105(11):782-90. PubMed ID: 23641043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter study directly comparing the diagnostic accuracy of gene expression profiling and immunohistochemistry for primary site identification in metastatic tumors.
    Handorf CR; Kulkarni A; Grenert JP; Weiss LM; Rogers WM; Kim OS; Monzon FA; Halks-Miller M; Anderson GG; Walker MG; Pillai R; Henner WD
    Am J Surg Pathol; 2013 Jul; 37(7):1067-75. PubMed ID: 23648464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic work-up of carcinoma of unknown primary: from immunohistochemistry to molecular profiling.
    Oien KA; Dennis JL
    Ann Oncol; 2012 Sep; 23 Suppl 10():x271-7. PubMed ID: 22987975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular gene expression profiling to predict the tissue of origin and direct site-specific therapy in patients with carcinoma of unknown primary site: a prospective trial of the Sarah Cannon research institute.
    Hainsworth JD; Rubin MS; Spigel DR; Boccia RV; Raby S; Quinn R; Greco FA
    J Clin Oncol; 2013 Jan; 31(2):217-23. PubMed ID: 23032625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study of treatment outcomes in patients with carcinoma of unknown primary site and a colorectal cancer molecular profile.
    Hainsworth JD; Schnabel CA; Erlander MG; Haines DW; Greco FA
    Clin Colorectal Cancer; 2012 Jun; 11(2):112-8. PubMed ID: 22000811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.